Figure 2From: A comparison of the clinical outcomes of patients with invasive lobular carcinoma and invasive ductal carcinoma of the breast according to molecular subtype in a Korean population BCSS and OS according to molecular subtype: luminal A(a,b), luminal B(c,d), HER2-overexpression (e,f), and triple negative (g,h). Back to article page